By continuing to use the site you agree to our Privacy & Cookies policy

NICE change could be 'good news' for skin cancer patients

A watchdog U-turn could allow thousands of patients with the deadliest form of skin cancer to receive a pioneering drug that helps the immune system destroy tumours.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units